Search
Sanofi SA
SNYAdd to Watchlist
42.625USD
+0.145+0.34%
Market hours 09/21, 11:56（ET）
102.14BMarket Cap
11.85P/E TTM
Sanofi SA (SNY) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Sanofi SA in the past month.
Buy
3 Strong Buy
2 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
54.693USD+26.78%
SNY Analyst Recommendation Trends
In the current month, SNY has received 2 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. SNY average Analyst price target in the last month is 54.693.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
3
3
3
3
4
2
2
2
2
2
4
4
4
5
5
5
5
5
3
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
10
10
10
10
10
10
SNY Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, SNY EPS is projected to reach 1.540 in FY2026Q3, following reported EPS of 0.166 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.03
1.03
1.14
1.54
1.07
Actual
-0.38
0.78
0.17
--
--
Surprise
-137.21%
-23.65%
-85.40%
--
--
FAQs
What is Sanofi SA's expected revenue for the next quarter?
Sanofi SA's expected revenue is 15.57B.
What is Sanofi SA's price target?
Analysts forecast that Sanofi SA's price target is USD 54.69, with the highest forecast at USD 64.26 and the lowest forecast at USD 45.00.
How have Sanofi SASNY's recent earnings per share performed?
The market expectation was USD 0.17, while Sanofi SASNY's earnings per share (EPS) for the previous quarter was USD 0.78. EPS for the next quarter is expected at USD 1.54.
What is the analyst rating for Sanofi SA?
Based on the ratings of Sanofi SA's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.